glp 1 impact on food industry Ozempic Could Crush the Junk Industry. But It Is Fighting Back Examining the Impact of GLP-1

Very involved

As these medications come in injectable form, they are administered as a once weekly injection under the skin (subcutaneously) in the belly, outer thighs, upper buttocks, or the back of the arms

GLP-1 receptor agonists, like Ozempic, Wegovy, Mounjaro, and Zepbound, initially developed for diabetes management, show promising potential in treating psoriasis and psoriatic arthritis (PsA)

The AOP framework does not argue against NAMs

From what I can tell, the best described mechanism for hair loss related to these novel weight loss agents is a telogen effluvium mechanism

The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin